Overview

Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA Patients

Status:
Completed
Trial end date:
2022-12-31
Target enrollment:
0
Participant gender:
Male
Summary
To compare clinical outcomes before and after using combination between moderate to vigorous-intensity physical activities and pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis in moderate to severe hemophilia A patients
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Chulalongkorn University
Treatments:
Factor VIII
Criteria
Inclusion Criteria:

- Severe Hemophilia A patients

Exclusion Criteria:

-